- Home
- CNTB vs MBOT Comparison
CNTB vs MBOT Comparison
Compare CNTB & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNTB | MBOT |
|---|---|---|
| Founded | 2012 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 135.7M | 114.9M |
| IPO Year | 2020 | 2000 |
Fundamental Metrics
Financial Performance| Metric | CNTB | MBOT |
|---|---|---|
| Price | $2.21 | $1.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $8.67 | $7.50 |
| AVG Volume (30 Days) | 677.5K | ★ 696.0K |
| Earning Date | 08-13-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 60.27 |
| EPS | N/A | ★ N/A |
| Revenue | $64,000.00 | ★ $116,887.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $119.77 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.23 | $1.60 |
| 52 Week High | $3.82 | $4.62 |
Technical Indicators
Market Signals| Indicator | CNTB | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 46.82 | 46.51 |
| Support Level | $2.14 | $1.75 |
| Resistance Level | $2.75 | $2.21 |
| Average True Range (ATR) | 0.23 | 0.08 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 10.87 | 28.45 |
Price Performance
Historical ComparisonAbout CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.